Ligand Pharmaceuticals
LGND
#4157
Rank
NZ$3.65 B
Marketcap
$189.60
Share price
3.73%
Change (1 day)
54.60%
Change (1 year)

Earnings for Ligand Pharmaceuticals (LGND)

Earnings in 2024 (TTM): NZ$8.33 Million

According to Ligand Pharmaceuticals's latest financial reports the company's current earnings are NZ$0.16 Billion. a decrease over its 2023 earnings that were of NZ$0.11 Billion. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Ligand Pharmaceuticals from 1994 to 2024

Annual earnings

Year Earnings Change
2024 NZ$9.67 M-91.37%
2023 NZ$0.11 B-7.59%
2022 NZ$0.12 B4%
2021 NZ$0.11 B296.42%
2020 NZ$29.43 M-97.97%
2019 NZ$1.45 B275.62%
2018 NZ$0.38 B237.48%
2017 NZ$0.11 B49.05%
2016 NZ$76.82 M55.41%
2015 NZ$49.43 M36.87%
2014 NZ$36.11 M29.59%
2013 NZ$27.86 M1309.35%
2012 NZ$1.97 M-43.97%
2011 NZ$3.52 M-113.19%
2010 -NZ$26.76 Million59.86%
2009 -NZ$16.74 Million-61.33%
2008 -NZ$43.29 Million-58.75%
2007 -NZ$0.11 Billion20.52%
2006 -NZ$87.07 Million81.27%
2005 -NZ$48.04 Million
2003 -NZ$33.45 Million-20.6%
2002 -NZ$42.12 Million4.38%
2001 -NZ$40.35 Million-48.83%
2000 -NZ$78.85 Million-19.74%
1999 -NZ$98.24 Million-19.06%
1998 -NZ$0.13 Billion126.71%
1997 -NZ$53.54 Million-5.83%
1996 -NZ$56.85 Million136.23%
1995 -NZ$24.07 Million-33.97%
1994 -NZ$36.45 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
NZ$8.03 B 82,930.08%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$0.11 Billion-1,214.77%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$7.66 B 79,066.64%๐Ÿ‡ฌ๐Ÿ‡ง UK
NZ$36.98 B 381,939.27%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$19.37 B 200,098.16%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$22.11 B 228,334.52%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$14.62 Billion-151,045.78%๐Ÿ‡บ๐Ÿ‡ธ USA
-NZ$1.04 Billion-10,782.76%๐Ÿ‡บ๐Ÿ‡ธ USA
NZ$30.41 B 314,113.66%๐Ÿ‡บ๐Ÿ‡ธ USA